“…About 11%-57% of the MLLs are associated with ADH [ [3] , [7] ] and 2%-30% are associated with DCIS [3] . The upgrade rate to DCIS for MLL with atypia is 8%-75% and for MLL without atypia is 2.8%-13% ( Table 1 ) [ [5] , [8] , [9] , [11] , [15] , [16] , [17] ]. The atypical hyperplasia can be found outside the area of MLL in 26% of the ADH and 88% of the ALH [4] , reflecting the heterogeneous background of these lesions and reaffirming the importance of a good sampling, not only the visible target.…”